Managing Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors Through Co-Targeting MEK/ERK Signaling

Lignende værker

• Update on third-generation EGFR tyrosine kinase inhibitors
  af: Gray, Jhanelle, et al.
  Udgivet: (2014)
• Overcoming acquired resistance to AZD9291, a third generation EGFR inhibitor, through modulation of MEK/ERK-dependent Bim and Mcl-1 degradation
  af: Shi, Puyu, et al.
  Udgivet: (2017)
• Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
  af: Westover, D, et al.
  Udgivet: (2018)
• Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
  af: Xu, Haiyuan, et al.
  Udgivet: (2019)
• Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports
  af: Shi, Xuefei, et al.
  Udgivet: (2020)